Merck & Co (NY: MRK )

81.54 USD UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Oct 27, 2021 Add to My Watchlist

Price and Volume

Volume	7,188
Open	81.54
Bid (Size)	80.70 (1)
Ask (Size)	81.15 (4)
Prev. Close	81.54
Today's Range	81.54 - 81.54
52wk Range	15.32 - 85.60
Shares Outstanding	2,531,374,696
Dividend Yield	3.19%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Gilead and Merck Initiate Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Lenacapavir and Investigational Islatravir for HIV-1 Treatment in Virologically Suppressed Adul

October 26, 2021

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the start of a Phase 2 clinical study evaluating an investigational...

Merck Presents New Data from Ongoing Phase 2b Clinical Trial Evaluating Efficacy and Safety of Investigational Islatravir in Combination With Doravirine Through 144 Weeks for HIV-1 Treatment at EACS 2

October 27, 2021

Merck Presents New Data from Ongoing Phase 2b Trial Evaluating Islatravir in Combination With Doravirine Through 144 Weeks for HIV-1 at EACS 2021

Performance

YTD	+0.72%	+0.72%
1 Month	+11.15%	+11.15%
3 Month	+4.10%	+4.10%
6 Month	+5.77%	+5.77%
1 Year	+4.55%	+4.55%

More News

The Medicines Patent Pool (MPP) and Merck Enter Into License Agreement for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, to Increase Broad Access in Low- and Middle-Income Countri

October 27, 2021

7 Stocks To Watch For October 28, 2021

Today 4:35 EDT

Earnings Preview For Merck & Co

October 27, 2021

Merck Inks Licensing Pact To Broaden Generic Manufacturing Of COVID-19 Antiviral

October 27, 2021

Merck Announces Positive Top-Line Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily Oral Fixed Dose Combination of Doravirine/Islatravir for the Treatment of People with HIV-1

October 25, 2021

Merck and Ridgeback Announce Initiation of a Rolling Review by the European Medicines Agency for Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of COVID-19 in Adults

October 25, 2021

2 Top Dividend Stocks That Can Safeguard Your Portfolio Against a Market Crash

October 27, 2021

Novavax is Now a Riskier Play, but Still One to Keep Your Eye On

October 25, 2021

3 Top COVID Stocks -- Are They Tricks or Treats?

October 26, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search form

The Kane Republican

Merck & Co (NY: MRK )

Price and Volume

Top News

Performance

More News